NKIRAS1 Antibody (aa96-113, clone 184C278)
Mouse Monoclonal Antibody
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Application
| WB, IHC-P |
---|---|
Primary Accession | Q9NYS0 |
Reactivity | Human, Mouse, Rat, Rabbit, Hamster, Monkey, Goat, Horse, Dog |
Host | Mouse |
Clonality | Monoclonal |
Clone Names | 184C278 |
Calculated MW | 22kDa |
Dilution | IHC-P (5 µg/ml), WB (0.5-1 µg/ml), |
Gene ID | 28512 |
---|---|
Other Names | NF-kappa-B inhibitor-interacting Ras-like protein 1, I-kappa-B-interacting Ras-like protein 1, Kappa B-Ras protein 1, KappaB-Ras1, NKIRAS1, KBRAS1 |
Target/Specificity | A synthetic peptide containing amino acid residues 96-113 of human kB-Ras1. |
Reconstitution & Storage | Short term 4°C, long term aliquot and store at -20°C, avoid freeze thaw cycles. |
Precautions | NKIRAS1 Antibody (aa96-113, clone 184C278) is for research use only and not for use in diagnostic or therapeutic procedures. |
Name | NKIRAS1 |
---|---|
Synonyms | KBRAS1 |
Function | Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB. |
Cellular Location | Cytoplasm. |
Tissue Location | Widely expressed.. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Atypical Ras-like protein that acts as a potent regulator of NF-kappa-B activity by preventing the degradation of NF-kappa-B inhibitor beta (NFKBIB) by most signals, explaining why NFKBIB is more resistant to degradation. May act by blocking phosphorylation of NFKBIB and mediating cytoplasmic retention of p65/RELA NF-kappa-B subunit. It is unclear whether it acts as a GTPase. Both GTP- and GDP-bound forms block phosphorylation of NFKBIB.
References
Fenwick C.,et al.Science 287:869-873(2000).
Ota T.,et al.Nat. Genet. 36:40-45(2004).
Chen Y.,et al.J. Biol. Chem. 278:23101-23106(2003).
Chen Y.,et al.Mol. Cell. Biol. 24:3048-3056(2004).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.